Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateNew HampshireIn Committee
SB 444: prohibiting the use of animal testing when other comparable methods are available.
Daniel Innis
SB 444 status: In Committee — Subcommittee Work Session: 09/30/2026 10:10 am GP 229 (updated Sep 14, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
71OUT OF 100
Score:71/100 civic fit
Risk:Low Risk
Impact:Moderate Impact 45/100
Constitutionality90%
Bipartisan70%
Public opinion85%
Bill summary
What changes
The bill creates a new chapter, 359-V, prohibiting private testing facilities from using traditional animal testing methods if a comparable alternative, waiver, or federal compliance path is available.
Who is affected
Commercial and private testing facilities; the bill explicitly excludes institutions of higher education.
Requirements and enforcement
Facilities must prioritize non-animal testing methods where available, apply for waivers, and submit detailed annual reports to the governor's commission on animal treatment.
Costs and funding
Fiscal impact is estimated at under $10,000; however, individual facilities will incur private costs for technology adoption and reporting.
When it takes effect
The bill takes effect on January 1, 2027, with the first reporting requirement due by January 20, 2028.
Potential benefits
Advances animal welfare, incentivizes modern biotechnological research methods, and improves public transparency.
Risks and tradeoffs
Operational burden on private labs and potential challenges in validating new alternative methods for specific regulatory contexts.
What is still unknown
The specific internal methodology criteria that state agencies will use to certify 'comparable' alternatives remain to be determined.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
45%
Benefits
- Incentivizes private sector investment in alternative testing methods
- Reduces potential long-term costs of traditional animal trials
- Aligns state testing standards with modern global market expectations
Risks
- Increases administrative compliance burdens for small testing facilities
- Mandates annual reporting creating ongoing operational overhead
- May shift competitive advantage toward institutions exempt from the law
Society
Positive outlook
85%
Benefits
- Advances humane treatment standards for vertebrate animals
- Reflects societal shift toward animal-free testing alternatives
- Promotes transparency in industry testing practices via public reporting
Risks
- Potential delays in product safety validation during method transition
- Concerns regarding the scope of exemptions for biomedical research
- Subjective interpretation of 'fewest possible number' of animals
Technology Industry
Positive outlook
80%
Benefits
- Drives market demand for computational toxicology platforms
- Promotes growth in bioinformatics and in-vitro testing systems
- Encourages integration of microphysiological systems into labs
Risks
- Compliance pressure on smaller firms using traditional legacy systems
- Requirement for staff retraining on new digital testing platforms
- Potential for technology-sector monopoly on required validation software
Civic Accountability
Positive outlook
85%
Benefits
- Mandates public disclosure of animal usage data
- Establishes oversight via the governor’s commission
- Requires annual, standardized reporting from private facilities
Risks
- Potential for information overload on the commission
- Reporting reliance on self-disclosure by testing facilities
- Risk of data misinterpretation by public-facing commissions
Public Health & Safety
Positive outlook
60%
Benefits
- Promotes scientifically relevant and modern safety data
- Encourages safer and potentially more accurate human-relevant modeling
- Maintains safety standards by requiring compliance with federal mandates
Risks
- Possible reduction in perceived safety if alternatives are less validated
- Ambiguity in how agencies determine 'comparable' method safety
- Risks to consumer safety if transitioning methods are underfunded
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
Testing facilities outside of higher education face significant new compliance and reporting obligations.
Analysis scope
Source metadata provides no information on potential implementation funding for the governor's commission.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.